Delivery Order SPE2DR25D2014-SPE2DR26FZ96C
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,358.85 for Trulicity 1.5 mg/0.5 mL pens on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,535.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 22, 2025, with completion targeted for August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,488.88 on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price contract, with a completion date of October 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order was awarded non-competitively as a competitively...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,096.22 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,248.58 to supply Trulicity 1.5 mg/0.5 mL pens on November 24, 2025, with completion scheduled for November 25, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,616.66 for Trulicity 1.5 mg/0.5 ml pen auto-injectors on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ96CDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,744.44 for Trulicity 3 mg/0.5 mL pens on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed price, non-set-aside contract was awarded competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the company's distribution hub in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order falls within the scope of AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement, which supplies a broad range of medications and medical commodities to support military healthcare programs globally. Trulicity, a diabetes management medication, represents the type of specialty pharmaceutical product the company routinely delivers through the DLA Medical Supply Chain to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's demonstrated capability to manage both small-value transactions and substantial pharmaceutical orders through firm fixed price contracts makes it a critical vendor for federal medical procurement, particularly within the Defense Department's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/10/25 |